Pharmafile Logo

The Need for and Impact of Rare Disease Education

Physicians are often told that when they hear hoofbeats, think horses, not zebras — to look for the most common cause of a patient’s symptoms first. While this advice may help them through most of their interactions, there are millions of patients worldwide whose health depends on their clinicians doing the exact opposite — considering zebras, and looking for rare diseases.

While rare diseases are individually rare, they are collectively common, affecting an estimated 263 to 446 million people1 worldwide. For most, the road to diagnosis is a long one, with the mean time to diagnosis stretching to 5-7 years, but sometimes more than 10 years.2-5 Along the way, these patients may be subjected to pain, worsening of symptoms, unnecessary diagnostic tests, and ineffective treatments.

To combat the challenges faced by clinicians, more education is needed, particularly as clinicians move past medical school and residency and into practice. In a survey of almost 1000 clinicians, the prevalence of rare diseases was underestimated by 50 to 500 times as compared with current European or US prevalence definitions; and almost two-thirds of clinicians said they never or rarely see patients with rare diseases.

- PMLiVE

The data show that not only do clinicians want and need education on rare diseases, but continuing medical education (CME/CE) on Medscape.org has a significant impact on clinicians’ knowledge and competence.

Between 2018 and May 2021, more than 245,000 unique clinicians from around the world engaged in rare disease educational activities on Medscape.org. These physicians had measurable improvements in their knowledge and competence after participating in the activities, as measured by their ability to correctly answer relevant questions pre versus post education, including:

- PMLiVE

Non-physicians saw similar increases in knowledge and competence, including

- PMLiVE

Most importantly, this means that 676,000+ patient visits per year now have physicians who are better prepared to identify patients who have a rare diseases, as measured by IQVIA data.

Education is having an impact, but more is needed to fully equip clinicians with the knowledge they need. Medscape Education is committed to developing the education clinicians need and provide it in a centralized location on Medscape.org. Pathways in Rare Disease is a destination page clinicians can return to at any time for the latest education across the spectrum of rare diseases.

- PMLiVE

To learn more about Medscape Education’s rare diseases education initiatives, please contact your Medscape Representative.

  1. Nguengang Wakap S, Lambert DM, Olry A, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Human Genet. 2020;28:165-173.
  2. Yan X, et al. Determining How far an adult rare disease patient needs to travel for a definitive diagnosis: a cross-sectional examination of the 2018 National Rare Disease Survey in China. Int J Environ Res Public Health. 2020;17:1757.
  3. Engel PA, et al. Physician and patient perceptions regarding physician training in rare diseases: the need for stronger educational initiatives for physicians. J Rare Disord. 2013;1:1-15.
  4. Global Genes. Accurate diagnosis of rare diseases remains difficult despite strong physician interest. 2014. Accessed January 18, 2023. https://globalgenes.org/2014/02/20/accurate-diagnosis-of-rare-diseases-remains-difficult-despite-strong-physician-interest-2/
  5. Marwaha S, et al. A guide for the diagnosis of rare and undiagnosed disease: beyond the exome. Genome Med. 2022;14:23.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Redefining Pediatric Epilepsy Care: Why We Must Move Beyond Symptom Suppression

For families navigating pediatric epilepsy, the condition dictates every moment of their lives. The constant, crippling “anticipatory anxiety” of when the next seizure might hit transforms daily activities like grocery…

What 90 Minutes of Live AI Case Practice Revealed About Physician Readiness

At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the practical and ethical use of AI. The format was case-based. The faculty presented…

Rethinking Prenatal Migraine Management: The Clinical Case for Neuromodulation

Disclaimer: Management of migraine in pregnancy typically combines lifestyle strategies, nonpharmacologic approaches, selected pharmacologic options when benefits outweigh risks, and, increasingly, noninvasive neuromodulation technologies.

Advancing the Frontier of Cancer Care: Medscape’s Mission at ESMO 2026

For more than 30 years, Medscape Education’s dedication has been centered on a single goal: building independent, accredited oncology education that improves patient outcomes. This year, at the European Society…

Using AI Responsibly in CME Outcomes Reporting

ICYMI at #AIS2026: using AI in outcomes reporting is a lot like onboarding a research assistant. There’s real efficiency in having the help, and a significant amount of background teaching,…

The Pulse of AI Innovation: From More Data to Better Care

At the European Society of Cardiology (ESC) Congress, two of cardiology’s most influential voices sat down to talk about artificial intelligence at Medscape’s ‘The Pulse of AI Innovation’ event: Professor…

Next-Level Clinical Practice, Real-World Impact: Evolving Patient Simulation with the Clinical Readiness Studio

Healthcare is changing rapidly, bringing unprecedented data and complex treatment pathways to the point of care. Clinical mastery requires active experience, the confidence to make decisions when real patient outcomes…

Medscape Sponsors The John Ritter Foundation’s “Evening From the Heart”

When independent, evidence-based education directly connects with clinicians at the point of care, clinical practice changes. Driven by this vital mission, Medscape Education was proud to sponsor The John Ritter…

From Booth to Bavaria: A Recap of Impact at ESC 2026

We have officially wrapped up another year at ESC. For Medscape Education, 4 days on the ground confirmed what 3 decades of cardiovascular education have already shown: when independent, evidence-based…

Why Modern Dermatology Demands Curiosity Over Precision

In the high-stakes world of healthcare research and product development, success has long been measured by rigid definitions of precision and predictable trajectories. However, as Dr. Hawa Dumbuya, Director of…